OMNIPAQUE INJECTION 300 mg I/ml
Product details
Registration number: SIN05924P
Classification: Prescription Only
Active ingredients: IOHEXOL 647 mg/ml EQV IODINE
Strength: 300 mg/ml
Dosage form: INJECTION
Route: INTRAVENOUS; INTRAVASCULAR; INTRACAVITARY; INTRA-ARTERIAL; INTRATHECAL
Registrant: GE HEALTHCARE PTE. LTD.
ATC code: V08AB02
HSA approval date: 17 May 1991
Manufacturer(s):
- GE HEALTHCARE IRELAND LIMITED (by Parametric Release)
- GE HEALTHCARE AS (by Parametric Release)
- GE HEALTHCARE (SHANGHAI) CO., LTD
Manufacturing country/countries: IRELAND; NORWAY; CHINA
What are the HSA registration number and classification for OMNIPAQUE INJECTION 300 mg I/ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN05924P
Classification: Prescription Only
What active ingredients and strength are recorded for OMNIPAQUE INJECTION 300 mg I/ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: IOHEXOL 647 mg/ml EQV IODINE
Strength: 300 mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for OMNIPAQUE INJECTION 300 mg I/ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAVENOUS; INTRAVASCULAR; INTRACAVITARY; INTRA-ARTERIAL; INTRATHECAL
Who is the recorded registrant for OMNIPAQUE INJECTION 300 mg I/ml?
According to the HSA dataset updated 7 August 2026:
Registrant: GE HEALTHCARE PTE. LTD.
Which manufacturers and countries are listed for OMNIPAQUE INJECTION 300 mg I/ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- GE HEALTHCARE IRELAND LIMITED (by Parametric Release)
- GE HEALTHCARE AS (by Parametric Release)
- GE HEALTHCARE (SHANGHAI) CO., LTD
Manufacturing country/countries: IRELAND; NORWAY; CHINA
Where can I look up OMNIPAQUE INJECTION 300 mg I/ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN05924P or the exact product name OMNIPAQUE INJECTION 300 mg I/ml. The general register link does not preselect this product.
What are the source dates for this OMNIPAQUE INJECTION 300 mg I/ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this OMNIPAQUE INJECTION 300 mg I/ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN05924P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)